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Abstract
Purpose: The objective of this research project was to identify proteins secreted from human lacrimal fluids
onto the extra-ocular surface of the eye that could be later used to predict eye health, disease, and age-related
changes. The identification of specific lacrimal proteins in relative quantities and patterns in younger versus
older patients may reflect both ocular and extra-ocular disease states.
Methods: This observational study collected samples of lacrimal fluid from 20 subjects between the ages of 18
and 25 years and 20 subjects over the age of 50 years with the use of Schirmer strips. The protein composition
of these lacrimal fluid samples was then analyzed to determine specific proteins that evidenced unique
patterns among the subject populations.
Results: The protein concentrations between the two age groups (n = 40) was significantly higher in the
younger patient group (1408.3 ug/mL versus 1152.5 ug/mL, p = 0.03). No consistent qualitative differences
in the protein bands were observed between the two different patient age groups. However, excising and
analyzing the outlying protein bands revealed unique proteins within the older patient group (aldehyde
dehydrogenase and serotransferrin precursor). Preliminary attempts were made to determine the presence of
proteins in lacrimal fluid that may originate from cells lining the ducts and blood vessels associated with the
ocular environment.
Conclusion: These preliminary results in age related differences in eye lacrimal fluid will contribute to future
research endeavors in order to determine which specific proteins were increased or decreased quantitatively in
the younger population, if any, and what role they might have in eye health, disease, and age-related changes.
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Abstract 
 
Purpose: The objective of this research project was to identify proteins secreted from human lacrimal fluids onto the 
extra-ocular surface of the eye that could be later used to predict eye health, disease, and age-related changes. The 
identification of specific lacrimal proteins in relative quantities and patterns in younger versus older patients may reflect 
both ocular and extra-ocular disease states. 
Methods: This observational study collected samples of lacrimal fluid from 20 subjects between the ages of 18 and 25 
years and 20 subjects over the age of 50 years with the use of Schirmer strips. The protein composition of these lacrimal 
fluid samples was then analyzed to determine specific proteins that evidenced unique patterns among the subject 
populations.  
Results: The protein concentrations between the two age groups (n = 40) were significantly higher in the younger patient 
group (1408.3 ug/mL versus 1152.5 ug/mL, p = 0.03). No consistent qualitative differences in the protein bands were 
observed between the two different patient age groups. However, excising and analyzing the outlying protein bands 
revealed unique proteins within the older patient group (aldehyde dehydrogenase and serotransferrin precursor).  
Preliminary attempts were made to determine the presence of proteins in lacrimal fluid that may originate from cells 
lining the ducts and blood vessels associated with the ocular environment. 
Conclusion: These preliminary results in age related differences in eye lacrimal fluid will contribute to future research 
endeavors in order to determine which specific proteins were increased or decreased quantitatively in the younger 
population, if any, and what role they might have in eye health, disease, and age-related changes. 
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Introduction 
 
The eye is an ocular organ capable of 
distinguishing between various shapes and colors in 
order to produce an elaborate vision field for humans. It 
is considered to be one of the most complex organs 
within the human body. It is often cited as an example of 
a supposed irreducible complexity due to its intricate 
anatomical parts, all of which are dependent upon each 
other for appropriate functionality.1 
 
An often-overlooked feature of the eye that truly 
contributes to its complex functionality is its 
surrounding lacrimal fluid.2 This extracellular fluid is 
secreted by the acinar and ductal cells of the lacrimal 
gland, located in the upper temporal part of the orbit 
within the lacrimal fossa.2,3 The secreted lacrimal fluid 
consists of water, electrolytes (sodium, potassium, 
calcium, magnesium, chloride, phosphate, and 
bicarbonate, etc.), protein (enzymes, growth factors, 
cytokines), and other small molecule metabolites (amino 
acids, urea, glucose, lactate, etc.), which serve to 
lubricate the ocular surface, provide oxygen to the 
avascular cornea and inhibit bacterial growth.2,4,5 
Additionally, without this fluid, light would not be 
appropriately refracted onto the retina.2,4 
 
Lacrimal fluid comprises the aqueous 
component of the eye’s tear film, which is classified into 
three main layers: the outer lipid layer, middle aqueous 
layer, and inner mucin layer.2,6 The lipid layer’s primary 
source is the Meibomian glands, which produce both 
non-polar and polar lipids dispersed with various 
proteins serving to stabilize the tear film.2,6 The mucin 
layer’s primary source is the goblet cell, and serves as a 
border between the tear film and the ocular surface.2,6 It 
has been demonstrated that the total protein 
concentration of normal lacrimal fluid within healthy 
individuals ranges anywhere from 6 to 11 mg/ml and 
contains anywhere from 500 to 1500 different proteins, 
of which 10 to 15 percent are considered to be 
extracellularly derived.6 
 
These proteins present within lacrimal fluid not 
only function to protect and nourish the eye, but may 
also serve as biomarkers to indicate the presence or 
absence of an underlying pathology.6 The variations in 
tear compositions have been shown to correlate with 
both ocular and extra-ocular conditions.6 Therefore, they 
are an ideal source for the identification of biomarkers 
that may indicate the presence or absence of disease, and 
have the potential to offer greater insight into the 
underlying pathology of different disease states.6 By 
identifying specific lacrimal proteins in relative 
quantities, their close relationship to both ocular and 
extra-ocular disease states may be better understood. 
 
A total of 1543 lacrimal fluid proteins were 
recently discovered and developed into a reference list.7 
Lysozyme, lactoferrin, sIgA, and GIIA phospholipase 
(PLA2) are only several of the important tear proteins 
that offer defense against pathogens through broad-
spectrum antimicrobial activity.6 Calgranulin A (S100 
A8), an inflammatory-related protein, has been revealed 
to be present in higher quantities in individuals with 
keratocojunctivitis sicca.6 Patients with allergic 
conjunctivitis were observed to have significant 
increases in tear IgE levels, osteopontin (an adhesive 
matrix protein), and substance P (a neurotransmitter 
involved with neurogenic inflammation).6 Collagenase 2 
(MMP-8) and gelatinase B (MMP-9) were both 
increased in people with ocular rosacea, a chronic 
inflammatory disease affecting the eye.6 Additionally, 
treatment with oral doxycycline in these individuals was 
shown to decrease levels of MMP-9 from a mechanism 
independent of its antimicrobial activity.6 
 
Among the extra-ocular disease states that have 
been linked to an increase in lacrimal proteins are 
diabetes mellitus and various cancers.6 Tear specific pre-
albumin (TSPA) concentrations were decreased and 
lysozyme increased in the tear fluid of diabetics with 
pre-proliferative diabetic retinopathy.6 Concentrations of 
nerve growth factor (NGF) were increased in the tear 
fluid of diabetics with proliferative diabetic retinopathy.6 
These findings indicate the potential to identify early-
onset diabetic ocular dysfunction.6 Lacryglobin was 
detected in higher concentrations in patients with breast, 
lung, colon, and prostate cancers when compared to non-
cancer patients.6,8 In a study with 50 subjects, roughly 80 
to 90 percent of patients with breast and lung cancer and 
100 percent of patients with colon and prostate cancer 
had detectable levels of lacryglobin in their lacrimal 
fluids, relative to the 60 percent of control patients.8 
Overall, the variations in tear fluid composition suggest 
that proteins and other tear components could become 
useful biomarkers of disease presence and severity. 
 
Because the collection technique can drastically 
affect the analysis of the tear fluid, a brief discussion of 
the advantages and disadvantages between the various 
lacrimal fluid collection techniques is warranted.6 The 
Schirmer’s strip test and glass capillary tubes are two of 
the most popular collection techniques.6,9 The 
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Schirmer’s strip test is commonly used in ophthamology 
clinics to aid in the diagnosis of dry eye.6,9 It consists of 
a strip that is placed inside the conjunctival sac (eyelid) 
for roughly five minutes or until the strip is filled with 
tear fluid.6,9 Although commonly used, this method can 
often cause discomfort and has the tendency to collect 
unwanted epithelial proteins from the surface of the 
cornea or conjunctiva.6,9 The glass capillary tube method 
involves placing the tip of the capillary tube in the lower 
tear meniscus to allow for the fluid to be naturally drawn 
into the tube.6 Although this technique theoretically 
allows for minimal contact, it assumes the person is 
experienced with the procedure.6 There is a risk of the 
capillary tube touching the ocular surface, especially 
with inexperienced individuals.6 Additionally, this 
process is generally very slow and is usually not possible 
in patients with a low tear fluid volume (dry eye, elderly, 
etc.).6 
 
A biomarker is typically defined as any biologic 
substance that can be objectively measured to indicate 
the presence, absence, or severity of a normal or 
pathological process, or a pharmacological response to a 
therapeutic intervention.10 Common biomarkers include, 
but are not limited to: B-type natriuretic protein (BNP) 
for heart failure, troponin for myocardial infarctions, 
low-density lipoprotein (LDL) for atherosclerotic 
cardiovascular disease, hemoglobin A1c for diabetes, 
and prostate specific antigen (PSA) for prostate cancer. 
The typical process for a biomarker development 
includes its initial discovery, where a potential 
biomarker is identified.10 Once identified, the biomarker 
can be linked to a normal process, pathological process, 
or response to a pharmacological intervention within the 
confirmation stage of development.10 If the biomarker is 
successfully linked to a specific process, it typically 
enters the validation and refinement stage where its 
relevance to the population can then be established.10 
Lastly, the biomarker is adopted once its clinical utility 
has been identified.10 
 
 The initial discovery stage of biomarker 
development, as its main purpose is to identify potential 
biomarkers that can be linked to various processes at a 
later time. Our goal was to identify proteins located in 
human lacrimal fluids that could be later used to predict 
eye health, disease, and age-related changes. The 
purpose of the research was to determine the age-related 
differences in tear fluid composition between different 
age groups.  We analyzed human lacrimal fluid from 
individuals of varying ages, and subsequently 
determined a relationship between the findings and the 
disease state, eye health, and age-related changes of the 
corresponding individuals. By looking at the variation in  
proteins within lacrimal fluids of patients in different age 
groups we hope to identify any variations that could 
potentially link a patient with a particular age group and 
possibly, at a later time, a specific disease. 
 
Materials and Methods 
 
Subject Enrollment 
 
Subjects were enrolled in the study using a quota 
sampling strategy. A quota of 20 to 25 individuals was 
set for the age groups of 18 to 24 years old and over 50 
years old. Individuals were conveniently selected from 
the Cedarville University School of Pharmacy student 
population and a local practicing optometrist’s patient 
database. Individuals who have worn contacts within the 
past year were excluded from the study. All of the 
sample collection and analysis was completed by 
professional students of the Cedarville University School 
of Pharmacy during the time period of August 2013 to 
January 2015, under the instruction and validation of a 
faculty advisor and a practicing optometrist.  IRB 
approval was obtained from the Institutional Review 
Board for Human Subjects Research of Cedarville 
University. 
 
Sample Collection 
 
Each subject was provided with information 
about the study upon their arrival at the Health Sciences 
Center of Cedarville University. The subject then 
entered the simulation clinic with two researchers and 
was asked to sign a consent form. If the subject indicated 
his or her willingness to participate in the study, he or 
she was assigned a subject number and the data 
collection process began. The first component of the 
process consisted of a short interview to record any 
aspects of the subject’s personal history that could affect 
the protein components of his or her lacrimal fluid, such 
as age, occurrence of laser eye surgery, use of eye drops, 
use of eyeglasses, any current or chronic health problems 
they may have, and birth control status. Once the 
interview concluded, a researcher collected a sample of 
the subject’s lacrimal fluid, one from each eye. While 
wearing gloves, the researcher used a Schirmer strip to 
collect a 30-50 microliter sample of lacrimal fluid from 
the lacrimal lake of the lower eyelid of each eye. The 
Schirmer strip was inserted inside the lower eyelid of 
each eye and remained there for approximately 2-5 
minutes, depending on the time needed for the correct 
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amount of sample to be collected. Strips were stored in a 
secure minus 80° C freezer until the time of analysis.  
 
Data Analysis 
 
The mass of sample collected with each 
Schirmer strip was recorded by taring a scale with a 
microfuge tube containing an unused Schirmer strip and 
then obtaining the mass of each microfuge tube 
containing a patient sample Schirmer strip. 
 
The lacrimal fluid sample was extracted from 
each Schirmer strip using  100 microliters/strip of tear 
extraction buffer (500mM NaCl, 0.5% tween 20, 
phosphate buffered saline, pH 7.4, 1% bovine serum 
albumin, protease inhibitors, plus 1 mM NaVO3, 1mM 
PMSF, and 1mM benzamidine). Extraction was 
performed for 1 hour at 4 °C with end-over-end rotation 
and collection of fluid by centrifugation for 5 minutes at 
13,500 rpms. A standard BCA  protein assay was 
utilized to quantitate the protein content of each 
sample.11 Polyacrylamide gel electrophoresis was 
utilized to separate collected proteins based on charge 
and molecular weight.12 
 
Proteins were localized in each gel using the 
Pierce® Silver Stain for Mass Spectrometry method.13 
This method is compatible with the process of protein 
digestion by enzymes to create peptide fragments for 
mass spectrometry analysis.13 Gel images were collected 
and photographed utilizing an iPad camera application. 
Unique protein bands from the gels were excised using a 
sterile razor, and each excised band was placed into 
individual microfuge tubes.  Images of the gels after the 
excision of the unique protein bands were obtained to 
confirm identity. The images of the gels were also 
recorded on a CCD camera with Alpha imager software. 
 
 Excised protein bands were processed for 
analysis by mass spectrometry by de-staining the bands 
with freshly prepared buffers.13 Following the 
completion of this protocol, selected excised gel pieces 
were sent to the University of Cincinnati Proteomics 
Laboratory where the preliminary analyses were 
completed utilizing mass spectrometry.  Additional 
analyses of the tear samples were conducted to 
determine the presence of proteins possibly shed from 
endothelial cells during normal cell turnover. To 
accomplish this secondary objective, we performed a 
standard dot blot method to search for the presence of 
immobilized proteins on nitrocellose membranes.14  
 
Five micrograms of lacrimal tear fluid were 
spotted onto the nitrocellulose membrane using a 
narrow-mouth pipette tip and dot blot apparatus. Once 
the membrane dried sufficiently, the non-specific sites 
were blocked by soaking the membrane in 5% BSA in 
TBS-T (20 mM Tris-HCl, 150 mM NaCl, pH 7.5, 0.5% 
Tween 20) for one hour at room temperature. Each 
membrane was incubated with the primary antibody 
diluted in BSA/TBS-T (0.1% BSA in TBS-T) for 30 
minutes at room temperature. Membranes were washed 
three times with TBS-T for 3-5 minutes per wash. 
Secondary antibodies conjugated with HRP were added 
to the membranes for 30 minutes at room temperature. 
Final washes were performed with TBS-T (first wash, 15 
minutes; second and third washes, 5 minutes each).  
After a final wash with TBS for 5 minutes, membranes 
were processed for enhanced chemiluminescence (ECL, 
GE Healthcare) for 1 minute before exposing it to the 
alpha-imager. 
 
Results 
 
Patient demographics 
 
Patients enrolled in this study were selected 
conveniently from the surrounding Cedarville/Xenia, 
Ohio area. Students within the Cedarville School of 
Pharmacy were selected for the young group and 
patients from the Cedarville and Xenia practice sites of 
Dr. Florkey were selected for the older patient group. A 
total of 40 patients were enrolled in the study (20 
patients per age group), and prior to providing samples 
patients were asked about their past medical history 
regarding: eye health, health concerns, chronic disease 
states, menopausal status, other factors that alter 
hormone levels, and age. All results were strictly patient 
reported. Chronic disease states were more prevalent in 
the old group (6 patients from the old group compared to 
1 from the young group). The young group had 10 males 
and 10 females, whereas the old group had 8 males and 
12 females. The average age for the young group was 22 
years old, with an average age of 60 years old for the old 
group (one patient in the old group did not have an age 
recorded). Male average age in the study was 21.7 years 
old and 59.8 years old for the young and old groups 
respectively. Female average age in the study was 22.2 
years old and 60.2 years old for the young and old 
groups respectively.  
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Lacrimal Fluid 
 
The young group produced an average larger 
volume of lacrimal fluid (LF) than the older group; 
0.0314 ± 0.008 g of LF collected from the young group 
compared to 0.0263 ± 0.005 g of LF from the old group. 
Eyes within the groups produced on average different 
volumes of LF. In the young group the right eye 
produced a greater volume of LF, 0.0323 ± 0.008 g 
compared to 0.0304 ± 0.008 g of LF from the left eye. 
Conversely, in the old group the left eye produced, on 
average, a greater volume of LF, 0.0272 ± 0.008 g 
compared to 0.0253 ± 0.003 g of LF collected from the 
right eye.    
 
BCA Protein Assay 
 
To examine the difference in protein 
concentration between groups, as well as between the 
left and right eyes, samples were analyzed by a BCA 
assay. Which revealed that the young group had a 
greater average concentration of protein in LF than the 
old group, 1408.33 ± 17.0 µg/mL compared to 1152.46 
± 16.3 µg/mL. A paired two-sample t-test revealed a 
statistically significant difference between protein 
concentrations for each group. In each group, the eye 
that produced more volume also had the greatest protein 
concentration. The young group averaged a protein 
concentration of 1578.91 ± 21.5 µg/mL for the right eye 
and 1224.94 ± 21.4 µg/mL for the left eye. The old 
group’s protein concentration did not vary as greatly as 
the young group. The old group’s left eye averaged a 
greater protein concentration (1159.93 ± 31.0 µg/mL) 
than the right eye (1144.99 ± 27.2 µg/mL).  
  
Pierce® Silver Stain 
 
In order to find and extract unique proteins from 
the samples, all samples were analyzed using the silver 
stain method. This analysis allowed the research team to 
observe all proteins found in LF that was collected, and 
select unique bands for further identification. Figures 1A 
and 1B are representative gels showing the migration of 
proteins and level of clarity. Initial observations were to 
identify bands that were found to be unique and 
presented differently from other proteins within the same 
gel. Any protein that was unique was excised, de-
stained, and sent for mass spectrometry analysis.  For 
this study proteins from the left eye of an older patient 
were analyzed in more detail. 
 
Figure 1A 
 
Figure 1B 
 
Figure 1A and 1B. Representative protein gels of 
separated lacrimal proteins obtained from human 
lacrimal fluid obtained from the left (L) and right (R) 
eyes absorbed onto Schirmer Strips. Proteins were 
separated on 8% percent PAGE gels at 100 nanograms 
per well. Molecular weight markers are indicated in 
kilodaltons (BioRad protein plus). Pierce silver stain 
protocol was used to stain proteins prior to mass 
spectrometry analysis.  Figure 1A represents samples 
from young patients.  Figure 1B represents Older 
patients, patient OL2 and OR2 were of interest in the 
initial mass spectrometry search.  In figure 1B, labels A, 
B, C and D represent bands isolated for more detailed 
analysis.  
 
 
 
 
 
A 
B 
 C D 
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MALDI-TOF/TOF and MASCOT 
 
After bands were excised, they were de-stained 
and sent for mass spectrometry in order to be identified. 
Theses 4 protein bands (Labeled A-D in figure 1B) were 
reduced, alkylated, digested with trypsin and identified 
by MALDI-TOF/TOF and a MASCOT search of the 
mammalian proteome. The proteins were cleaved into 
peptides for peptide identification and potential 
proteomic identification. Band A (OL2) was determined 
to be made of human serum albumin in a complex with 
myristic acid and tri-iodobenzoic acid, and Ig alpha-1 
chain (C region). Band B (OL2) had the exact same 
identification as Band A. Band C (OL2) contained 
aldehyde dehydrogenase, another tentative identification 
of the contents (meaning further confirmation would be 
required to accurately identify the protein) was IgG1 
(Heavy chain H Lambda). Finally, Band D (OL2) 
contained serotransferrin precursor and albumin (isoform 
CRA_t).   
 
Fibronectin Type lll Repeat in Lacrimal Fluid 
 
All lacrimal fluids from Schirmer strips from 
young and older patients were bound to nitrocellulose in 
a dot blot format and probed for proteins known to be 
associated with endothelial cells, CD31 and fibronectin 
type lll repeats. Two patient samples had detectable 
levels of fibronectin type lll repeat protein, in Row A 
spot A2 and A10 (numbering pictured below each dot 
blot). The dot blot was stripped and re-probed with anti-
tubulin antibody as a negative control, results are shown 
in figure 3, no detectable reactivity. 
 
 
 
 
 
Figure 2.  Dot blot demonstrating fibronectin type lll 
repeat like protein present in extracted tear fluid.  Spots 
A2 and A10 (asterisk) are samples of young patients that 
did not wear contacts or have any diagnosis related to an 
eye disorder and are positive for reactivity to fibronectin 
type lll repeat.  Spots C3 and H7 are positive controls, 
purified protein from HEK293 cells.  D8 is fluid from 
tear blink an artificial wetting agent for eyes. 
 
 
 
 
Figure 3. The dot blot used for fibronectin type lll 
reactivity was stripped and re-probed with a mouse anti-
tubulin antibody to demonstrate non-reactivity with an 
unrelated antibody.   
 
Discussion  
 
The purpose of this study was to identify any 
differences in the protein makeup of lacrimal fluid 
between young and old patients. The resulting 
differences could then be utilized as a baseline for future 
studies to identify which specific proteins might 
correlate with disease and eye health. Preliminary gel 
electrophoresis runs revealed some minor but distinct 
variations between young and old patient groups. There 
were three unique protein bands located in one particular 
patient (Left eye patient 5), and one was from the young 
group (Left eye patient 4). After excising the three 
outlying protein bands and sending them to be analyzed, 
the proteins were identified to be albumin complexed 
with myristic acid, albumin isoform CRA, partial 
immunoglobulin, aldehyde dehydrogenase, and 
serotransferrin precursor. Both albumin with myristic 
acid and partial immunoglobulin were found in the 
young and old groups. However, aldehyde 
dehydrogenase and serotransferrin precursor were 
unique to the outlying protein band within the old group. 
 
The presence of aldehyde dehydrogenase and 
serotransferrin precursor protein may indicate the 
occurrence of age-related changes to the eye. However, 
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these proteins were only linked to the left eye of one 
specific subject. The subject, in which these proteins 
were identified, was a female, 66 years of age, with a 
past medical history of osteoporosis. Additionally, her 
eyes were dilated 20 minutes prior to a lacrimal sample 
being taken. Thus, the presence of aldehyde 
dehydrogenase and serotransferrin in the lacrimal sample 
could have been due to inflammation from her chronic 
osteoporosis or due to the fact that her eyes were dilated 
beforehand. Because the dilatory drops get metabolized 
very quickly on the ocular surface and should not be 
present after roughly 10 minutes, it is not believed that 
the dilatory drops themselves had an effect on the 
lacrimal fluid composition. However, the dilatory effects 
were still present, and could have contributed to an 
increase in certain proteins within the subject’s lacrimal 
fluid.  Because only one elderly subject’s lacrimal fluid 
was observed to contain these unique proteins, future 
studies would need to be conducted in order to 
hypothetically link these proteins to actual ocular age-
related changes or inflammatory disease states and if 
dilation in some way affects protein expression 
independently of disease status.  No other patients in the 
study had pupil dilation prior to sample collection. 
 
During the course of the study, the 
concentrations of the proteins in the lacrimal fluid were 
able to be calculated. When comparing the means, it was 
found that the young subjects had a significantly higher 
protein concentration within their lacrimal fluid (p= 
0.03). Future studies could be aimed at determining what 
specific proteins, if any, were increased in younger 
patients, and what role they might have in eye health, 
disease, or various age-related changes. 
 
 
A secondary objective was to determine if 
proteins known to be present on normal endothelial cells 
such as CD31, fibronectin type lll repeats and Von 
Willebrand’s factor could be detected in lacrimal tear 
fluid from young and older patients.  Out of a total of 40 
patients, two young patients had detectable levels of 
fibronectin type lll protein.  Further analyses are being 
conducted to determine contribution to the tear fluid in 
these patients.  Various eye inflammatory or injury 
settings could present with shed endothelial cell 
components because of leaky vessels or exuded cell 
pieces due to apoptosis and cell fragmentation.15 
   
Conclusion 
 
 Protein content within the lacrimal fluids was 
significantly higher in the younger population relative to 
the older group. Although there were no significant 
differences in the type of proteins found between the two 
groups, there were obvious but small variations from the 
protein bands from samples of two subjects. These 
unique bands revealed two different proteins. Work is 
ongoing to determine the reason for the proteins in the 
lacrimal fluid. The data that was gathered can be used in 
future studies in order to determine which proteins were 
increased in the younger population, and what role they 
might have in eye health, disease, and age-related 
changes. 
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